{
  "trial_id": "NCT00093860",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Subjects are patients referred for evaluation of chronic orthostatic intolerance.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients enter into the therapeutic trial after they are determined to have NCS with SAI in a screening evaluation.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Participation in this protocol is offered to individuals 10-17 years of age, independently of gender, race, ethnicity, religion, or any other demographic or sociopolitical classifications.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "To be eligible to enter this study, the patient must have a minimum frequency of pre-syncope of at least 1 event/2 months, or syncope of at least once/4 months.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The severity of the symptoms should be of such severity as to alter the individual's quality of life or routines of life.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Age: Minors younger than 10 years old and pregnant female subjects between 10 and 17 years of age will be excluded.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Risk: A candidate subject is excluded if, in the judgment of the Principal Investigator, protocol participation would place the subject at substantially increased acute medical risk.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Disqualifying Conditions: A candidate subject is excluded if there is a disqualifying condition. Examples of disqualifying conditions are history of asthma or chronic obstructive pulmonary disease requiring bronchodilators, hepatic or renal failure, atrioventricular block of any degree, bradycardia, symptomatic congestive heart failure, severe anemia, psychosis, refractory ventricular arrhythmias, insulin-dependent diabetes mellitus, or psychiatric disorders requiring continuous drug treatment.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Medications: A candidate subject is excluded if clinical considerations require that the patient continue treatment with a drug likely to interfere with the scientific results.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has abdominal pain and vomiting, drinks around 60 units of alcohol per week, smokes 22 cigarettes per day, and has leukocytosis (19.5), urea of 8.5, high CRP (145), high amylase (1200) and Glc level of 15.",
  "_meta": {
    "topic_id": "21",
    "trial_id": "NCT00093860",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}